17
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Ultrastructural Features of Apoptosis in Human Pituitary Adenomas

, , , , , & show all
Pages 85-92 | Published online: 10 Jul 2009

References

  • Granville DJ, Carthy CM, Hunt DWC, McManus BM. Apoptosis: molecular aspects of cell death and disease. Lab Invest. 1998; 78: 893–913.
  • Wyllie AH, Kerr JF, Currie AR. Cell death: the signifcance of apoptosis. Int Rev Cytol. 1980;68:251–306.
  • Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide ranging implications in tissue kinetics. Br J Cancer. 1972;26:239–257.
  • Wyllie AH. Glucocorticoid -induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature. 1980; 284: 555–556.
  • Gavrlell Y, Sherman Y, Ben -Sansson SA. Identifcation of programmed cell death in situ via specifc labeling of nuclear DNA fragmentation. J Cell Biol. 1992;119:493–501.
  • Gorcyca W, Gong J, Darynkiewicz Z. Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assays. Cancer Res. 1993;53:1945–1951.
  • Wijsman JH, Jonker RR, Keijzer R, Van de Velde CJH, Cornelisse CJ, Van Dierendonck JH. A new method to detect apoptosis in paraffn sections: in situ end -labeling of fragmented DNA. J Histochem Cytochem. 1993;41:7–12.
  • Ansari B, Coates PJ, Greenstein BD, Hall PA. In situ end -labelling detects DNA strand breaks in apoptosis and other physiological and pathological states. J Pathol. 1993;170:1–8.
  • Darzynkiewicz Z, Bedner E, Traganos F, Murakami T. Critical aspects in the analysis of apoptosis and necrosis. Hum Cell. 1998;11:3–12.
  • Charriaut -Marlangue C, Ben -Ari Y. A cautionary note on the use of the TUNEL stain to determine apoptosis. Neuroreport. 1995;7:61–64.
  • Saraste A. Morphologic criteria and detection of apoptosis. Herz. 1999; 24: 189–195.
  • Kulig E, Jin L, Quian X, et al. Apoptosis in nontumorous and neoplastic human pituitaries: expression of the Bcl -2 family of proteins. Am J Pathol. 1999;154:767–774.
  • Kontogeorgos G, Sambaziotis D, Piaditis G, Karameris A. Apoptosis in human pituitary adenomas: a morphologic and in situ end -labeling study. Mod Pathol. 1997;10:921–926.
  • Saraste A, Pulkki K. Morphologic and biochemical hallmarks of apoptosis. Cardiovasc Res. 2000;45:528–537.
  • Horvath E, Scheithauer BW, Kovacs K, Lloyd RV. Regional neuropathology: hypothalamus and pituitary. In: Graham DI, Lantos PL, eds., Green®eld’s Neuropathology, ed. 6. London: Arnold; 1997:1007–1094.
  • Kerr JF, Winterford CM, Harmon BV. Apoptosis: its signifcance in cancer and cancer therapy. Cancer. 1994;73:2013–2026.
  • Stadelmann C, Lassmann H. Detection of apoptosis in tissue sections. Cell Tissue Res. 2000;301:19–31.
  • Hacker G. The morphology of apoptosis. Cell Tissue Res. 2000;301:5–17.
  • Saitoh T, Murakami H, Hatsumi N, Matsushima T, Naruse T. Detection of VP -16 -treated HL -60 cell apoptosis by TUNEL electron microscopy. Ultrastruct Pathol. 2000;24:99–103.
  • Sanders EJ, Wride MA. Ultrastructural identifcation of apoptotic nuclei using the TUNEL technique. Histochem J. 1996; 28: 275–281.
  • Collins JA, Schandi CA, Young KK, Vesely J, Willingham MC. Major DNA fragmentation is a late event in apoptosis. J Histochem Cytochem. 1997;45:923–934.
  • Green DR, Reed JC. Mitochondria and apoptosis. Science. 1998; 281: 1309–1312.
  • Janicke RU, Sprengart ML, Wati MR, Porter AG. Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J Biol Chem. 1998;273:9357–9360.
  • Horvath E. Ultrastructural markers in the pathologic diagnosis of pituitary adenomas. Ultrastruct Pathol. 1994;18:171–179.
  • Henics T, Wheatley DN. Cytoplasmic vacuolation, adaptation and cell death: a view on new perspectives and features. Biol Cell. 1999; 91: 485–498.
  • Fenyves AM, Behrens J, Spanel -Borowsky K. Cultured microvascular endothelial cells (MVEC) differ in cytoskeleton, expression of cadherins and fbronectin matrix. J Cell Sci. 1993; 106: 879–890.
  • Wilson RG J r, Tahir SK, Mechoulam R, Zimmerman S, Zimmerman AM. Cannabinoid enantiomer action on the cytoarchitecture. Cell Biol Int. 1996;20:147–157.
  • Henics T, Wheatley DN. Vacuolar cytoplasmic phase separation in cultured mammalian cells involves the microflament network and reduces motional properties of intracellular water. Int J Exp Pathol. 1997;78:343–354.
  • Huot J, Houle F, Rousseu S, Deschesnes RG, Shah GM, Landry J. SAPK2/ p38 -dependent F -actin reorganization regulates early membrane blebbing during stress-induced apoptosis. J Cell Biol. 1998; 143: 1361–1373.
  • Mills J C, Stone NL, Pittman RN. Extranuclear apoptosis: the role of the cytoplasm in the execution phase. J Cell Biol. 1999; 146: 703–708.
  • Orgnero de Gaisan EM, Maldonado CA, Aoki A. Fate of degenerating lactotrophs in rat pituitary gland after interruption of lactation: a histochemical and immunocytochemical study. Histochem J. 1993;25:150–165.
  • Nolan LA, Kavanagh E, Lightman SL, Levy A. Anterior pituitary cell population control: basal cell turnover and the effects of adrenalectomy and dexamethasone treatment. J Neuroendocrinol. 1998;10:207–215.
  • Levy A. Mitosis and apoptosis in the pituitary gland: tumour formation or hyperplasia? Baillieres Best Pract Res Clin Endocrinol Metab. 1999;13:353–365.
  • Kakeya T, Takeuchi S, Takahashi S. Epidermal growth factor, insulin, and estrogen stimulate development of prolactin - secreting cells in cultures of GH3 cells. Cell Tissue Res. 2000; 299: 237–243.
  • Drewett N, Jacobi JM, Willgoss DA, Lloyd HM. Apoptosis in the anterior pituitary gland of the rat: studies with estrogen and bromocriptine. Neuroendocrinology. 1993;57:89–95.
  • Lee SY, Ahn BT, Baik SH, Lee BL. Tamoxifen inhibits GH3 cell growth in culture via enhancement of apoptosis. Neurosurgery. 1998; 43: 116–123.
  • Ahlbom E, Grandison L, Zhivotovsky B, Ceccatelli S. Termination of lactation induces apoptosis and alters the expression of the Bcl -2 family members in the rat anterior pituitary. Endocrinology. 1998; 139: 2465–2471.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.